Duloxetine [Cymbalta; Eli Lilly] 60/120mg versus placebo in the treatment of fibromyalgia syndrome.

Trial Profile

Duloxetine [Cymbalta; Eli Lilly] 60/120mg versus placebo in the treatment of fibromyalgia syndrome.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2011

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jun 2008 US FDA approves duloxetine for the management of fibromyalgia according to Eli Lilly media release.
    • 22 Aug 2007 Results have been reported.
    • 22 Aug 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top